We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
-13.32%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$86.3B
AUM Growth
-$18.2B
Cap. Flow
-$2.03B
Cap. Flow %
-2.36%
Top 10 Hldgs %
12.71%
Holding
2,392
New
138
Increased
818
Reduced
1,174
Closed
217

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$354M
2
VZ icon
Verizon
VZ
+$307M
3
HCA icon
HCA Healthcare
HCA
+$256M
4
MPC icon
Marathon Petroleum
MPC
+$239M
5
CMCSA icon
Comcast
CMCSA
+$231M

Sector Composition

Rank Sector Weight
1 Healthcare 20.11%
2 Technology 18.25%
3 Consumer Discretionary 14.02%
4 Industrials 10.23%
5 Financials 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRPT icon
1676
Freshpet
FRPT
$3.22B
$629K ﹤0.01%
19,555
+1,852
+10% +$64.5K
BWXT icon
1677
BWX Technologies
BWXT
$15.6B
$628K ﹤0.01%
16,419
-201,225
-92% -$9.99M
SLM icon
1678
SLM Corp
SLM
$5.15B
$626K ﹤0.01%
75,308
-28,358
-27% -$282K
TITN icon
1679
Titan Machinery
TITN
$445M
$625K ﹤0.01%
47,566
-1,118
-2% -$16.6K
TRNO icon
1680
Terreno Realty
TRNO
$7.49B
$625K ﹤0.01%
17,760
-23,477
-57% -$876K
MBWM icon
1681
Mercantile Bank Corp
MBWM
$1.05B
$623K ﹤0.01%
22,037
-25,043
-53% -$777K
SOHU
1682
Sohu.com
SOHU
$357M
$622K ﹤0.01%
35,715
GTHX
1683
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$622K ﹤0.01%
32,475
+13,424
+70% +$503K
AVNS
1684
DELISTED
Avanos Medical
AVNS
$621K ﹤0.01%
13,864
-518
-4% -$27.1K
HRI icon
1685
Herc Holdings
HRI
$5.61B
$621K ﹤0.01%
23,878
-6,191
-21% -$216K
BRSP
1686
BrightSpire Capital
BRSP
$648M
$620K ﹤0.01%
39,260
-3,586
-8% -$68.2K
MBUU icon
1687
Malibu Boats
MBUU
$567M
$620K ﹤0.01%
17,828
-3,833
-18% -$168K
SEM
1688
DELISTED
Select Medical
SEM
$620K ﹤0.01%
74,964
-28,593
-28% -$274K
ATNI icon
1689
ATN International
ATNI
$492M
$616K ﹤0.01%
+8,618
New +$673K
AIT icon
1690
Applied Industrial Technologies
AIT
$13.3B
$611K ﹤0.01%
11,331
-1,703
-13% -$111K
CLF icon
1691
Cleveland-Cliffs
CLF
$6.99B
$609K ﹤0.01%
79,252
+58,607
+284% +$586K
CVCO icon
1692
Cavco Industries
CVCO
$4.55B
$609K ﹤0.01%
4,673
-1,328
-22% -$240K
SYNA icon
1693
Synaptics
SYNA
$4.15B
$609K ﹤0.01%
16,367
-16,153
-50% -$607K
LADR
1694
Ladder Capital
LADR
$1.24B
$607K ﹤0.01%
39,221
-3,415
-8% -$58K
AAMI
1695
Acadian Asset Management
AAMI
$3.19B
$605K ﹤0.01%
56,606
-22,432
-28% -$270K
OSB
1696
DELISTED
Norbord Inc.
OSB
$605K ﹤0.01%
22,745
-61,737
-73% -$1.68M
CMPR icon
1697
Cimpress
CMPR
$2.31B
$604K ﹤0.01%
5,838
-5,970
-51% -$693K
RP
1698
DELISTED
RealPage, Inc.
RP
$603K ﹤0.01%
12,521
SCHW
1699
Charles Schwab
SCHW
$187B
$600K ﹤0.01%
14,455
-93,249
-87% -$4.22M
PMT
1700
PennyMac Mortgage Investment
PMT
$842M
$599K ﹤0.01%
32,147
+6,315
+24% +$126K

Similar funds

AQR Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, AQR Capital Management held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

AQR Capital Management's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

  • AQR Capital Management's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
  • AQR Capital Management added most to Merck in Q4 2018, an estimated $354M increase.
  • AQR Capital Management's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
  • AQR Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
  • AQR Capital Management's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
  • AQR Capital Management opened 138 new positions and closed 217 in Q4 2018.
  • AQR Capital Management's portfolio value fell 17% quarter-over-quarter to $86.3B.

Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.